You are here

Clinical Trials: Cord Blood

Conditions:   Safety Issues;   Effect of Drugs
Interventions:   Other: autologous umbilical cord blood stem cells;   Drug: 0.9% Sodium-chloride
Sponsor:   Guangdong Women and Children Hospital
Not yet recruiting
Condition:   Androgenic Alopecia
Interventions:   Other: conditioned media of umbilical cord blood-derived stem cells;   Other: Placebo
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Conditions:   Acute Myeloid Leukemia;   Acute Lymphocytic Leukemia;   Biphenotypic/Undifferentiated Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplasia;   Relapsed Large Cell Lymphoma;   Mantle Cell Lymphoma;   Hodgkin Lymphoma;   Burkitt Lymphoma;   Relapsed T-Cell Lymphoma;   Lymphoplasmacytic Lymphoma
Interventions:   Drug: Fludarabine (FLU);   Drug: Cyclophosphamide (CY);   Drug: Total Body Irradiation (TBI);   Drug: Tacrolimus (Tac);   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte Colony-Stimulating Factor (G-CSF);   Drug: Busulfan (BU);   Drug: Melphalan;   Drug: MGTA 456 Infusion
Sponsor:   Masonic Cancer Center, University of Minnesota
Not yet recruiting
Condition:   Ulcerative Colitis (UC)
Interventions:   Biological: Adipose-cord mesenchymal stromal cells (A-MSCs);   Other: Conventional drugs
Sponsor:   Liaocheng People's Hospital
Recruiting
Conditions:   CD19 Positive;   Mantle Cell Lymphoma;   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent Follicular Lymphoma;   Refractory B-Cell Non-Hodgkin Lymphoma;   Refractory Diffuse Large B-Cell Lymphoma;   Refractory Follicular Lymphoma
Interventions:   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Carmustine;   Drug: Cytarabine;   Drug: Etoposide;   Biological: Filgrastim;   Drug: Melphalan;   Biological: Rituximab;   Biological: Umbilical Cord Blood-derived Natural Killer Cells
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
Conditions:   Bone Marrow Failure Syndrome;   Thalassemia;   Sickle Cell Disease;   Diamond Blackfan Anemia;   Acquired Neutropenia in Newborn;   Acquired Anemia Hemolytic;   Acquired Thrombocytopenia;   Hemophagocytic Lymphohistiocytoses;   Wiskott-Aldrich Syndrome;   Chronic Granulomatous Disease;   Common Variable Immunodeficiency;   X-linked Lymphoproliferative Disease;   Severe Combined Immunodeficiency;   Hurler Syndrome;   Mannosidosis;   Adrenoleukodystrophy
Interventions:   Drug: Thiotepa--single daily dose;   Drug: Thiotepa--escalated dose
Sponsor:   University of Florida
Not yet recruiting
Conditions:   Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia in Remission;   Myelodysplastic Syndromes;   Other Acute Leukemias
Interventions:   Biological: Unmanipulated Umbilical Cord Blood (UCB);   Biological: AB-110
Sponsor:   Angiocrine Bioscience
Not yet recruiting
Condition:   Cerebral Palsy
Interventions:   Biological: Infusion of allogeneic umbilical cord blood;   Biological: Infusion of MSCs
Sponsors:   Joanne Kurtzberg, MD;   The Marcus Foundation
Not yet recruiting
Condition:   Multiple Myeloma
Intervention:   Biological: ECT-001 (UM171) expanded cord blood
Sponsors:   Ciusss de L'Est de l'Île de Montréal;   ExcellThera;   Centre de Commercialisation en Immunothérapie du Cancer (C3i)
Not yet recruiting
Conditions:   Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Acute Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic-Myeloproliferative Diseases;   Myeloproliferative Disorder;   Non Hodgkin Lymphoma;   Hodgkin Lymphoma;   Leukemia
Interventions:   Radiation: Total Body Irradiation;   Drug: Cyclosporine;   Drug: Mycophenolate Mofetil;   Drug: Tocilizumab;   Drug: Filgrastim
Sponsor:   Memorial Sloan Kettering Cancer Center
Recruiting

Pages